SHARE Cancer Support
Score (What’s this?)
Perlu Network score measures the extent of a member’s network on Perlu based on their connections, Packs, and Collab activity.
SHARE supports, educates, and empowers people affected by breast cancer or ovarian cancer. All of our services are provided by survivors who've been there.
Each month, we’ll be curating study opportunities, new clinical trials, research results, news articles, personal perspectives, and upcoming events of interest to women and families affected by breast, ovarian, or metastatic breast cancer. Statement of Improvement to USPSTF Regarding BRCA Gene Testing Recommendations SHARE, among many others, has co-signed this statement to the U. S. Preventive Services Task Force regarding their recommendations for risk assessment, genetic counseling, and genetic testing of BRCA related cancers. After his wife, Dr. Uzma Yunus, passed away from Stage 4 breast cancer in January of 2019, Dr. Raina writes about the downfall of comparing metastatic breast cancer to a "chronic disease". I had no idea that I had this incredible inner strength until I had to face this incredible challenge."
Even though I was BRCA negative, my mom, aunts, cousins all developed breast cancer. My mom had developed breast cancer when I was 23. With my additional knowledge, my aunts went to breast surgeons and to Sloan Kettering which was known to be excellent for breast surgery at that time. She was of sound mind and began the Side By Side program in her 80's, whereby SHARE ladies would lecture incoming Medical Students at NYU Medical Center and Westchester Medical Center about "Doctor-Patient Communication.
This study gives us a preliminary answer to the question, “Can we try PARP after PARP to treat recurrent Ovarian Cancer? Plus we saw promising phase II trial results for a Pembrolizumab, Bevacizumab, and Cyclophosphamide combination for Ovarian Cancer. This study is looking at the effects of risk reducing surgery for those who have a hereditary risk of ovarian cancer to remove Fallopian tubes before menopause and then remove the ovaries after menopause. If you'd like to hear more about research updates from the conference, we hope you can join SHARE as we catch up with Dr. Stephanie Blank, Director of Gynecologic Oncology at Mt. Sinai Health Systems.
SHARE is excited to announce the launch of mobile iOS app My MBC & Me, designed to empower people with metastatic breast cancer and improve communication and decision-making with their doctors. My MBC & Me is a mobile iOS app that empowers people living with metastatic breast cancer (MBC) to better manage their treatment and communication with their care team. It provides disease and treatment information and tracks appointments, medication, treatment history, side effects, and symptoms. My MBC & Me allows users to upload and pin their research, notes, voice memos, and questions directly to calendar appointments, promoting more productive doctor appointments and enhanced patient self-advocacy.